OverviewSuggest Edit

Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field. The Company is organized into three business segments: Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes a broad range of products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women’s health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas: immunology, infectious diseases and vaccines, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a broad range of products used in the orthopaedic, surgery, cardiovascular, diabetes care and vision care fields.

... Show more
TypePublic
Founded1886
HQNew Brunswick, US
Websitejnj.com
Employee Ratings3.9

Latest Updates

Employees (est.) (Nov 2018)134,000
Job Openings2,930
Revenue (FY, 2017)$76.5 B(+7%)
Share Price (Feb 2019)$134.5

Key People/Management at Johnson & Johnson

Alex Gorsky

Alex Gorsky

Chairman, Board of Directors and Chief Executive Officer
Joaquin Duato

Joaquin Duato

Executive Vice Chairman
Peter Fasolo

Peter Fasolo

EVP, Chief HR Officer
Ashley McEvoy

Ashley McEvoy

Company Group Chairman, Consumer Medical Devices
Jorge Mesquita

Jorge Mesquita

Executive Vice President, Worldwide Chairman, Consumer
Michael Sneed

Michael Sneed

Worldwide Vice President, Global Corporate Affairs & Chief Communication Officer
Show more

Johnson & Johnson Office Locations

Johnson & Johnson has offices in New Brunswick, Neenah, Wallis, Norco and in 51 other locations
New Brunswick, US (HQ)
One Johnson & Johnson Plaza
Greenville, US
204 Greenville Blvd SW
Buenos Aires, AR
Mendoza 1259
Yerevan, AM
12 Martiros Saryan St, office 7
Broadway, AU
Locked Bag 5
Minsk, BY
70 Ulitsa Myasnikova 5th floor
Show all (57)
Report incorrect company information

Johnson & Johnson Financials and Metrics

Johnson & Johnson Revenue

Embed Graph
View revenue for all periods
Johnson & Johnson's revenue was reported to be $76.45 b in FY, 2017 which is a 6.3% increase from the previous period.
USD

Revenue (Q3, 2018)

20.3b

Gross profit (Q3, 2018)

13.8b

Gross profit margin (Q3, 2018), %

67.6%

Net income (Q3, 2018)

3.9b

Market capitalization (13-Feb-2019)

360.6b

Closing stock price (13-Feb-2019)

134.5

Cash (30-Sep-2018)

16.1b

EV

374.0b
Johnson & Johnson's current market capitalization is $360.6 b.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017

Revenue

74.3b70.1b71.9b76.5b

Revenue growth, %

4%(6%)3%6%

Cost of goods sold

22.7b21.5b21.7b25.4b

Gross profit

51.6b48.5b50.2b51.1b
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

17.4b17.8b17.1b17.5b18.5b17.8b17.8b18.8b19.7b20.0b20.8b20.3b

Cost of goods sold

5.3b5.4b5.2b5.3b5.3b5.5b5.4b5.8b6.9b6.6b6.9b6.6b

Gross profit

12.1b12.4b11.9b12.2b13.1b12.3b12.4b13.0b12.7b13.4b13.9b13.8b

Gross profit Margin, %

70%70%69%70%71%69%70%69%65%67%67%68%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

20.9b14.5b13.7b19.0b17.8b

Accounts Receivable

11.7b11.0b10.7b11.7b13.5b

Prepaid Expenses

4.0b3.5b3.0b3.3b2.5b

Inventories

7.9b8.2b8.1b8.1b8.8b
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2018

Cash

12.0b10.6b13.6b13.9b18.6b18.2b20.9b12.6b15.7b14.6b17.6b16.1b

Accounts Receivable

11.5b12.0b11.4b11.4b12.1b11.8b12.3b13.3b13.2b14.2b14.1b

Prepaid Expenses

3.7b3.1b3.0b3.3b3.1b2.6b2.8b3.0b2.9b2.6b2.6b

Inventories

8.1b8.3b8.2b8.2b8.5b8.5b8.9b9.7b9.5b9.0b8.8b8.7b
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

13.8b16.3b15.4b16.5b1.3b

Depreciation and Amortization

4.1b3.9b3.7b3.8b5.6b

Inventories

(622.0m)(1.1b)(449.0m)(249.0m)581.0m

Accounts Payable

1.8b955.0m(3.0m)656.0m2.7b
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2018

Net Income

4.3b8.8b12.2b4.3b8.5b12.7b4.4b8.2b12.0b4.4b8.3b12.3b

Depreciation and Amortization

895.0m1.8b2.7b891.0m1.8b2.7b912.0m2.1b3.8b1.7b3.5b5.2b

Inventories

(276.0m)(537.0m)(719.0m)(190.0m)(443.0m)(408.0m)(368.0m)(421.0m)(193.0m)(322.0m)(491.0m)(777.0m)

Accounts Payable

(2.5b)(2.2b)1.6b(2.3b)(1.0b)(1.2b)(2.0b)(1.2b)339.0m(1.7b)(49.0m)731.0m
USDY, 2018

EV/CFO

23.4 x

Debt/Equity

0.5 x

Debt/Assets

0.2 x

Financial Leverage

2.4 x
Show all financial metrics

Johnson & Johnson Operating Metrics

FY, 2014FY, 2015FY, 2016FY, 2017Jun, 2018

Manufacturing Facilities

134 121 119 125

Facilities

265 250 230 260 260

Countries

60 60 60 60

Discovery Projects

100 150
Show all operating metrics

Johnson & Johnson Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
Auris HealthJanuary 23, 2019
Ci:z HoldingsOctober 23, 2018$2.10 b
Zarbee's NaturalsJuly 27, 2018
OrthotaxyFebruary 20, 2018
Actelion PharmaceuticalsJanuary 26, 2017$30 b
Abott Medical OpticsSeptember 16, 2016$4.33 b
Vogue InternationalJune 02, 2016$3.30 b
Novira TherapeuticsNovember 08, 2015
NeoStrata Company, Inc.September 26, 2015
XO1March 20, 2015
Show more

Johnson & Johnson Revenue Breakdown

Embed Graph

Johnson & Johnson revenue breakdown by business segment: 34.8% from Medical Devices, 47.4% from Pharmaceutical and 17.8% from Consumer

Johnson & Johnson revenue breakdown by geographic segment: 17.6% from Asia-Pacific, Africa, 7.9% from Western Hemisphere excluding US, 22.4% from Europe and 52.1% from United States

Report incorrect company information

Johnson & Johnson Online and Social Media Presence

Embed Graph
Report incorrect company information

Johnson & Johnson News and Updates

Johnson & Johnson supplier seeks bankruptcy over talc lawsuits

A key supplier of talc used in Johnson & Johnson's baby powder filed for Chapter 11 bankruptcy on Wednesday in the wake of multibillion-dollar lawsuits alleging its products caused ovarian cancer and asbestos-related mesothelioma.

Johnson & Johnson is buying a Silicon Valley surgical robotics startup for $3.4 billion (JNJ)

Pharmaceutical giant Johnson and Johnson is buying surgical robotics company Auris Health for $3.4 billion. "In this new era of health care, we're aiming to simplify surgery, drive efficiency, reduce complications and improve outcomes for patients, ultimately making surgery safer," Ashley McEvoy,…

Johnson & Johnson will acquire surgical robotics company Auris Health

Johnson & Johnson subsidiary Ethicon, Inc. has agreed to acquire surgical robotics company Auris Health, Inc. for approximately $3.4 billion in cash, the health-products company announced Wednesday. The deal also includes contingent payments of up to $2.35 billion that can be made upon reaching…

Johnson & Johnson to buy surgical robotics firm Auris in $3.4 bln deal

Healthcare conglomerate Johnson & Johnson said on Wednesday it would buy privately held surgical robotics company Auris Health Inc for about $3.4 billion in cash.

Johnson & Johnson to buy Auris Health for $3.4 billion

The purchase gives J&J, one of the world's largest maker of health products, an entry into robotics and builds on the company's partnership with Alphabet's Verily.

Huge Growth on Corrective Lenses Market 2019: By Key Vendors like Cooper, Johnson & Johnson, Valeant Pharmaceuticals, Novartis, Corning, Bausch, Zeiss, and Verilog

A corrective lens is a lens typically worn in front of the eye to improve vision. The most common use is to treat refractive errors: myopia, hypermetropia, astigmatism, and presbyopia. Glasses or "spectacles" are worn on the face a short distance in front of the eye. Posted via Industry Today. Follo…
Show more
Report incorrect company information

Johnson & Johnson Company Life and Culture

Report incorrect company information

Johnson & Johnson Frequently Asked Questions

  • When was Johnson & Johnson founded?

    Johnson & Johnson was founded in 1886.

  • Who are Johnson & Johnson key executives?

    Johnson & Johnson's key executives are Alex Gorsky, Joaquin Duato and Peter Fasolo.

  • How many employees does Johnson & Johnson have?

    Johnson & Johnson has 134,000 employees.

  • What is Johnson & Johnson revenue?

    Latest Johnson & Johnson annual revenue is $76.5 b.

  • What is Johnson & Johnson revenue per employee?

    Latest Johnson & Johnson revenue per employee is $570.5 k.

  • Who are Johnson & Johnson competitors?

    Competitors of Johnson & Johnson include Henkel, Edgewell Personal Care and Colgate Palmolive.

  • Where is Johnson & Johnson headquarters?

    Johnson & Johnson headquarters is located at One Johnson & Johnson Plaza, New Brunswick.

  • Where are Johnson & Johnson offices?

    Johnson & Johnson has offices in New Brunswick, Neenah, Wallis, Norco and in 51 other locations.

  • How many offices does Johnson & Johnson have?

    Johnson & Johnson has 57 offices.